Researchers announce new advance in body 'chemical switch' study

March 5, 2012
This is the model of the human P2X1 receptor for ATP,. The three subunits that make up the functional receptor are shown in red, white and blue. Credit: University of Leicester

Scientists investigating a 'biochemical switch' linked to strokes and heart disease claim to have made an advance in understanding how it is 'turned on'.

The breakthrough is announced today in the prestigious science journal .

The work was led by a team at the University of Leicester, working in collaboration with Cardiff University, to investigate the 'biochemical switch' identified as the P2X1 receptor. It was funded by the Wellcome Trust and the British Foundation.

Lead researcher Professor Richard Evans, of the University of Leicester Department of Cell Physiology & Pharmacology, said: "P2X1 are protein molecules expressed on blood platelets which are cells involved in blood clotting. Drugs that block these receptors have the potential to reduce "dangerous" blood clotting that leads to strokes and heart attacks.

"Our research has looked at how the P2X1 receptor is "turned on". By biochemical studies and purifying the P2X1 receptor and using an electron microscope we have 'visualised' the receptor and detected changes in its shape when it is activated.

"The P2X1 receptor is made of three identical parts and we have shown that activation leads to these twisting against each-other. We found that if we chemically locked the receptor to stop this twisting, then the P2X1 receptor could not be fully activated.

"This is important as it gives the first realistic insight into how these novel receptors are turned on.

"This work will help to develop drugs that can stop the P2X1 receptor being "turned on" and would be useful to prevent and heart attack."

The research project was undertaken at the University of Leicester in the Department of Cell Physiology & Pharmacology and with Ralf Schmid in the University of Leicester Department of Biochemistry, along with Mark Young at Cardiff University.

Explore further: New advance announced in reducing 'bad' cholesterol

Related Stories

Key growth factor identified in T cell leukemia

August 1, 2011

Blocking a growth factor receptor cripples cancer growth in a form of T cell leukemia, according to a study published online on August 1 in the Journal of Experimental Medicine.

Recommended for you

Formaldehyde damages proteins, not just DNA

September 29, 2016

The capacity of formaldehyde, a chemical frequently used in manufactured goods such as automotive parts and wood products, to damage DNA, interfere with cell replication and cause cancer inspired new federal regulations this ...

Synthetic 3D-printed material helps bones regrow

September 28, 2016

A cheap and easy to make synthetic bone material has been shown to stimulate new bone growth when implanted in the spines of rats and a monkey's skull, researchers said Wednesday.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.